Adastra’s Application for Controlled Substances Dealer’s Licence Under Review by Health Canada

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra’s Application for Controlled Substances Dealer’s Licence Under Review by Health Canada2021-09-15T12:32:05+00:00

Phyto Extractions Inc. Completes Acquisition of PerceiveMD, a Multidisciplinary Centre for Medical Cannabis and Psychedelic Therapies

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Phyto Extractions Inc. Completes Acquisition of PerceiveMD, a Multidisciplinary Centre for Medical Cannabis and Psychedelic Therapies2021-09-15T12:32:40+00:00

Phyto Extractions Announces Name Change to Adastra Holdings Ltd.

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Phyto Extractions Announces Name Change to Adastra Holdings Ltd.2021-08-27T16:05:55+00:00

Phyto Extractions Inc. Provides Update on Proposed Acquisition

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Phyto Extractions Inc. Provides Update on Proposed Acquisition2021-08-23T11:38:00+00:00

Phyto Extractions Submits Application for Dried Cannabis Flower Sales Licence

Langley, BC / Accesswire / August 19, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (Frankfurt: D2EP) (“Phyto Extractions™”, “Phyto” or the “Company”) is a holder of a federal licence to process and sell cannabis extract products, edibles, and topicals under the Cannabis Act. The Company is pleased to announce that it has submitted a licence amendment to Health Canada that, if approved, will enable Phyto to sell dried cannabis flower to provincially authorized distributors and retailers and registered medical patients.
Phyto Extractions Submits Application for Dried Cannabis Flower Sales Licence2021-10-20T17:13:07+00:00

Phyto Extractions’ Shatter Run Visits 420th Retailer on Final Leg of Cross-Country Sales Tour

Langley, BC / Accesswire / August 18, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (Frankfurt: D2EP) (“Phyto Extractions™”, “Phyto” or the “Company”) strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Phyto Extractions™’ is known for its iconic concentrate products and brand success, built during the legacy market era. Shatter is Phyto’s newest product line to launch in the Canadian medical and adult-use markets and hit shelves this summer in British Columbia, Alberta, Saskatchewan, Manitoba and Ontario.
Phyto Extractions’ Shatter Run Visits 420th Retailer on Final Leg of Cross-Country Sales Tour2021-08-18T13:15:00+00:00

Phyto Extractions Inc. Announces Proposed Acquisition of PerceiveMD, a Multidisciplinary Centre for Medical Cannabis and Psychedelic Therapies

Langley, BC / Accesswire / June 2, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (“Phyto Extractions™” or the “Company”) is pleased to announce that it has entered into a share purchase agreement dated August 10, 2021 (the “Share Purchase Agreement”) pursuant to which the Company has agreed to acquire, indirectly through its wholly-owned subsidiary Adastra Labs Inc. (“Adastra”), all the issued and outstanding shares of 1225140 B.C. Ltd., doing business as PerceiveMD (“PerceiveMD”), from the shareholders (the “Vendors”) of PerceiveMD (the “Acquisition”).
Phyto Extractions Inc. Announces Proposed Acquisition of PerceiveMD, a Multidisciplinary Centre for Medical Cannabis and Psychedelic Therapies2021-08-11T09:22:00+00:00

Phyto Extractions’ Secures Biomass Supply Agreement

Langley, BC / Accesswire / July 12, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (Frankfurt: D2EP) (“Phyto Extractions™, “Phyto” or the “Company”) strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. To this end Phyto Extractions™ has secured a supply agreement for dried cannabis with a Canadian Licence Holder.
Phyto Extractions’ Secures Biomass Supply Agreement2021-07-12T08:59:00+00:00

Phyto Extractions’ RV visits retailers in cross-country tour

Langley, BC / Accesswire / June 30, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (Frankfurt: D2EP) (“Phyto Extractions™, “Phyto” or the “Company”) strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Phyto Extractions™’ is known for its iconic concentrate product – Shatter and brand success as it was built during the legacymarket era. Shatter is Phyto’s newest product line to launch in the Canadian medical and adult-use markets, and hit shelves this Summer, in BC, AB, SK, MB & ON.
Phyto Extractions’ RV visits retailers in cross-country tour2021-06-30T09:05:00+00:00
Go to Top